Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8263575
APP PUB NO 20090215715A1
SERIAL NO

11886931

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The compounds are phosphoramidate derivatives of nucleoside compounds such as cladribine, isocladribine, fludarabine and clofarabine useful in the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NUCANA BIOMED LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Congiatu, Costantino Porto Torres, IT 1 23
McGuigan, Christopher Cardiff, GB 46 1233
Mills, Kenneth Cardiff, GB 4 100

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation